The invention provides a compound of Formula (I)
or a pharmaceutically acceptable salt thereof; wherein
G is
R
1
, R
2
and R
3
are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
Provided are peptide nucleic acid derivatives targeting a part of the human HIF-1α pre-mRNA. The peptide nucleic acid derivatives potently induce exon skipping to yield splice variants of HIF-1α mRNA in cells, and are useful to treat indications or conditions involving the overexpression of HIF-1α.
Steric factors in amide-directed metalations of N,N-dialkyl-6-methoxynaphthalene-2-carboxamides: synthesis of a sterically perturbed acylnaphthol
作者:Rajeshwar D. Bindal、John A. Katzenellenbogen
DOI:10.1021/jo00391a001
日期:1987.7
BINDAL, RAJESHWAR D.;KATZENELLENBOGEN, J. A., J. ORG. CHEM., 52,(1987) N 1, 3181-3185
作者:BINDAL, RAJESHWAR D.、KATZENELLENBOGEN, J. A.
DOI:——
日期:——
HIF 1-ALPHA ANTISENSE OLIGONUCLEOTIDES
申请人:OliPass Corporation
公开号:US20210292767A1
公开(公告)日:2021-09-23
Provided are peptide nucleic acid derivatives targeting a part of the human HIF-1α pre-mRNA. The peptide nucleic acid derivatives potently induce exon skipping to yield splice variants of HIF-1α mRNA in cells, and are useful to treat indications or conditions involving the overexpression of HIF-1α.